News

BioSpace2d
Makary, Prasad Lay Out Mission for FDA in Journal Kennedy Called ‘Corrupt’
FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...
Medpage Today on MSN3d
FDA Officials Lay Out Vision for Agency
The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...
pharmaphorum2d
Makary, Prasad set out their vision for the FDA
Makary and Prasad also repeat various themes repeatedly visited by Kennedy on his Make America Healthy Again (MAHA) soapbox, ...
Post and Courier2d
Commentary: Keep FDA moving forward, not backward
When Vinay Prasad was tapped to lead the Food and Drug Administration’s Center for Biologics Evaluation and Research, the health care world braced for its effect. Known for his critical analyses ...
Fierce Biotech2d
FDA aims for 'rapid or instant' drug reviews, with AI tool initially assessing applications
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
MIT Technology Review22h
Here’s what food and drug regulation might look like under the Trump administration
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...
New Republic26d
An Anti-Science MAHA Extremist Is Playing a Major Role at the FDA
If there’s anything that Dr. Vinay Prasad, the controversial new appointee to lead the Center for Biologics Evaluation and Research, or CBER, a top office at the Food and Drug Administration ...
BioSpace9d
FDA’s Prasad Vows To Make Rare Disease Drugs Available at ‘First Sign of Promise’
The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines ...
Yahoo Finance21d
FDA CBER Director Dr. Vinay Prasad to Keynote NORD's Inaugural Rare Disease Scientific Symposium, Convening Top Researchers, Industry Leaders, and Federal Regulators
(PRNewsFoto/National Organization for Rare Disorders (NORD)) Vinay Prasad, MD ... Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), will deliver the keynote ...
Hosted on MSN22d
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
T he US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and ...
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...